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BACKGROUND: Carcinomas in children are rare and have not been well studied.
METHODS: We conducted a population-based case–control study and examined associations between birth characteristics and
childhood carcinomas diagnosed from 28 days to 14 years during 1980–2004 using pooled data from five states (NY, WA, MN,
TX, and CA) that linked their birth and cancer registries. The pooled data set contained 57 966 controls and 475 carcinoma cases,
including 159 thyroid and 126 malignant melanoma cases. We used unconditional logistic regression to calculate odds ratios (ORs)
and 95% confidence intervals (CIs).
RESULTS: White compared with ‘other’ race was positively associated with melanoma (OR¼ 3.22, 95% CI 1.33–8.33). Older maternal
age increased the risk for melanoma (ORper 5-year age increase¼ 1.20, 95% CI 1.00–1.44), whereas paternal age increased the risk
for any carcinoma (OR¼ 1.10per 5-year age increase, 95% CI 1.01–1.20) and thyroid carcinoma (ORper 5-year age increase¼ 1.16, 95%
CI 1.01–1.33). Gestational age o37 vs 37–42 weeks increased the risk for thyroid carcinoma (OR¼ 1.87, 95% CI 1.07–3.27).
Plurality, birth weight, and birth order were not significantly associated with childhood carcinomas.
CONCLUSION: This exploratory study indicates that some birth characteristics including older parental age and low gestational age
may be related to childhood carcinoma aetiology.
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In contrast to adults, carcinomas in children are extremely rare
with an estimated annual incidence among those 0–14 years of age
of 6.3 cases per million (Surveillance, Epidemiology, and End
Results, 2008). The incidence of childhood carcinomas increases
with age with most cases being diagnosed after age 14 years.
The major childhood carcinoma subtypes are renal, hepatic,
gonadal, adrenocortical, thyroid, nasopharyngeal, and malignant
melanoma (Steliarova-Foucher et al, 2005). Thyroid carcinoma
and melanoma comprise 60% of cases (Surveillance, Epidemiology,
and End Results, 2008). As is the case for adults, there is a female
predominance for both thyroid carcinoma and malignant mela-
noma (Pizzo and Poplack, 2006). Both of these subtypes are more
common in whites than blacks. The incidence of paediatric
malignant melanoma has increased over recent decades for
unknown reasons. Notably, from 1992 to 2007, the incidence of
paediatric malignant melanoma has increased significantly at an
average rate of 4.8% per year (Surveillance, Epidemiology, and
End Results, 2008).
The current understanding of the aetiology of the two most
common paediatric carcinomas, thyroid carcinoma and malignant
melanoma, is predominantly based on case-series reports and
studies of rare syndromes. Syndromes associated with thyroid
carcinomas include the following: familial adenomatous polyposis,
multiple endocrine neoplasia type 2, Cowden syndrome, Carney
complex, Pendred syndrome, and Werner syndrome (Richards,
2010). Xeroderma pigmentosum, a DNA repair disorder, is
associated with an increased risk of paediatric melanoma (Pizzo
and Poplack, 2006). Germline mutations in CDKN2A and CDK4
(Udayakumar and Tsao, 2009) have been linked to familial
melanoma, however mutations in both of these genes have been
infrequently reported in young onset melanoma (Tsao et al, 2000;
Berg et al, 2004; Debniak et al, 2008). Other biological risk factors
for childhood melanoma include giant congenital melanocytic nevi,
familial dysplastic nevus syndrome, fair skin, light hair colour, blue
or green eyes, immunosuppression, and atypical or numerous nevi
(Jen et al, 2009). Ionising radiation exposure is an established risk
factor for adult and childhood thyroid carcinoma (Ron, 2007).
Numerous adult melanoma studies have noted an increased risk in
relation to sun exposure (Schottenfeld and Fraumeni, 2006),
however the extent to which this is associated with childhood
melanoma is unclear (Whiteman et al, 1997; Youl et al, 2011).
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Early life is thought to be critical for cancer development in
children (Boice and Miller, 1999; Greaves, 2003). To our knowl-
edge, no studies have specifically examined the association
between birth characteristics and childhood carcinomas. Using
data from a registry-based linkage study, our objective was to
conduct an exploratory analysis of associations between factors
recorded in birth records and childhood carcinomas, both overall
and separately for the two major subtypes (thyroid carcinoma and
malignant melanoma). Because of the size and scope of this study,
it may offer additional clues to the aetiology of carcinomas
in children.
MATERIALS AND METHODS
Study procedures have been reported in detail previously (Johnson
et al, 2009; Puumala et al, 2009; Spector et al, 2009; Carozza et al,
2010; Chow et al, 2010). Institutional Review Board approvals
were obtained from each state’s health department and participat-
ing institutions before conducting the study. Individuals who
were diagnosed with childhood cancer during 1980–2004 were
identified through the population-based central cancer registries
of California, Minnesota, New York (excluding New York City),
Texas, and Washington states. Briefly, childhood cancer cases in
each state’s cancer registry were linked to their respective birth
certificates using sequential deterministic or probabilistic record
linkage (Jaro, 1995). Cases were classified according to the
International Classification of Childhood Cancer 3rd edition
(Steliarova-Foucher et al, 2005). All cases of melanoma were
malignant. Age at diagnosis in months was obtained from cancer
registry records. Controls were randomly selected from each state’s
birth registry in ratios to cases that varied from 1 to 10. Frequency
matching was used in four states and individual matching in one
(CA); year of birth was a matching factor in all states although
two also matched on sex (CA, TX).
Additional criteria were applied before pooling to ensure
uniformity of data. Cases that were also selected as controls in
the case-cohort sampling strategy employed by Minnesota and
New York were excluded from the control group in this analysis.
California cases included those diagnosed at o28 days old, whom
we subsequently excluded for consistency with other states.
Subjects with reported Down syndrome (n¼ 100) were excluded,
although it should be noted that Down syndrome was not recorded
in Texas before 1984 or in Washington before 1989. The final
pooled data set included 17 672 cases and 57 966 controls.
Statistical analyses
Odds ratios (ORs) and 95% confidence intervals (CIs) were
calculated by unconditional logistic regression (SAS version 9.1,
SAS, Cary, NC, USA); individual matching in the California data
set was broken for this reason. Race was categorised as white and
non-white using maternal race as a proxy for the child’s race.
We modelled associations with parental age both as continuous
variables in 5-year increments and as categorical variables (o25,
25–29, 30–34, andX35 years). Categorical variables were used to
assess the appropriateness of the log linear model for associations
between parental age and childhood carcinomas. Each parent’s
age was examined in separate models and in models that
included maternal and paternal age variables. Gestational age
was categorised as preterm (o37 weeks), term (37–42 weeks), and
post-term (442 weeks). Birth weight was modelled as a
continuous variable in 500-g increments and in categories using
the following cutoffs for low (o2500 g), normal (2500–4000 g),
and high birth weight (44000 g). All models were adjusted for
state and the matching variables sex and birth year. Because
knowledge about risk factors for childhood carcinomas is sparse
we included all available potential confounders of associations
between birth characteristic and childhood carcinoma. Therefore,
in addition to state, birth year, and sex, models included
gestational age, plurality, birth weight, birth order and maternal
or paternal age. Effect modification on the multiplicative scale was
assessed by including the cross product of the variables of interest
in the logistic regression model. We included only subjects with
complete data on all variables. The percentage of cases and
controls with missing data on the variables included in this
analysis was similar for sex (0% vs 0.02%), maternal age (0% vs
0.04%), paternal age (11% vs 11%), plurality (0% vs 0.6%), birth
weight (0% vs 0.6%), gestational age (6.1% vs 4.6%), birth order
(3.4% vs 2.6%), and maternal race (3.2% vs 1.5%). The number
of subjects that were excluded from each model is detailed in the
table 2 footnote. ORs were considered statistically significant if
the P-value was p0.05.
RESULTS
A total of 475 children diagnosed with carcinomas between 1980
and 2004 were identified in the pooled data set (Table 1). Thyroid
carcinomas (n¼ 159) were most common followed by melanomas
(n¼ 126), and together constituted more than half (60%) of the
carcinomas in this study. The median diagnosis age was 11.4 years
for carcinomas overall (data not shown) with most cases being
diagnosed between 10 and 14 years overall and for most subtypes.
More females were diagnosed with carcinomas than males
particularly for thyroid carcinomas. By race, there were notable
differences for melanoma where very few cases were non-white.
This is in contrast to renal cell carcinomas and nasopharyngeal
carcinomas where a larger percentage were non-white, 44% and
38%, respectively, compared with controls (14.7% (data not
shown)). Because of the small number of cases for most cancer
sites, associations with birth characteristics are presented for all
carcinomas combined and for the two sites with 100 or more cases
(malignant melanoma and thyroid carcinoma).
Maternal white race compared with ‘other’ race conferred a
significantly increased risk for melanoma (OR¼ 3.27, 95% CI
1.33–8.06) but not for all carcinomas or thyroid carcinoma
(Table 2).
Maternal age modelled as a continuous variable was associated
with a marginally significant increased risk for childhood
carcinomas overall (ORper 5-year increase¼ 1.09, 95% CI 0.99–1.20).
Both thyroid carcinoma and melanoma showed a positive linear
maternal age effect that was significant for melanoma (ORper 5-year
increase¼ 1.20, 95% CI 1.00–1.44). In models that categorised
maternal age, there was a consistent nonsignificant pattern of
increasing risk with advancing maternal age category for all
carcinomas. However, there was some evidence for an association
of older maternal age for malignant melanoma where all maternal
age categories were associated with elevated risks compared with
the reference group and for thyroid carcinoma in the offspring
of women born to mothers X35 vs o25 years (OR¼ 1.87, 95%
CI 1.01–3.48). There was no significant effect modification by
birth year category (1975–1984 vs 1985–2004) between maternal
age modelled as a continuous variable and all carcinomas, thyroid
carcinomas, or malignant melanomas.
Paternal age modelled as a continuous variable was associated
with a significant positive linear trend for childhood carcinomas
overall (ORper 5-year increase¼ 1.10, 95% CI 1.01–1.20) and thyroid
carcinoma (ORper 5-year increase¼ 1.16, 95% CI 1.01–1.33) and a
nonsignificant positive linear trend for malignant melanoma
(OR¼ 1.13, 95% CI 0.96–1.32). In models where paternal age
was modelled categorically, the risk for all childhood carcinomas
and thyroid carcinomas specifically generally increased with
increasing paternal age, consistent with the linear model of
paternal age; however all estimates were imprecise. There was no
significant effect modification by birth year category (1975–1984
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vs 1985–2004) between paternal age modelled as a continuous
variable and all carcinomas, thyroid carcinomas, or malignant
melanomas. In models that included maternal and paternal age, the
independent effects of each were attenuated (data not shown).
Plurality, birth weight, and birth order were not significantly
associated with all carcinomas, thyroid carcinoma, or melanoma.
Gestational age o37 weeks vs 37–42 weeks was associated with a
significant increased risk of thyroid carcinoma (OR¼ 1.87, 95%





























0–4 17.7 4.4 27.0 41.5 66.7 0 0 11.1 0 12.9
5–9 20.6 20.1 17.5 24.4 23.8 37.5 23.1 11.1 60.0 18.8
10–14 61.7 75.5 55.6 34.2 9.5 62.5 76.9 77.8 40.0 68.2
Female (%) 55.0 74.0 41.0 39.0 67.0 44.0 46.0 100 40.0 44.0
Non-white (%)b 12.6 7.8 4.1 22.5 19.1 44.0 45.5 12.5 0 17.7
a91% (n¼ 77) were found in other tissue sites and 9% (n¼ 8) were classified as having an unknown primary site. bA total of 15 cases (6 thyroid carcinomas, 5 malignant
melanomas, 1 hepatocellular carcinoma, 2 nasopharyngeal carcinomas, and 1 gonadal carcinoma) had missing data on maternal race.
Table 2 Associations between birth characteristics and any childhood carcinoma, thyroid carcinomas, and malignant melanomas diagnosed from
0–14 years




no. (%) OR 95% CI
Cases
no. (%) OR 95% CI
Cases
no. (%) OR 95% CI
Maternal racea,b
White 45 671 (85) 371 (87) 0.98 0.74 1.31 130 (92) 1.54 0.82 2.88 109 (96) 3.27 1.33 8.06
Other 8057 (15) 56 (13) 1.0 Reference 11 (8) 1.0 Reference 5 (4) 1.0 Reference
Maternal age (years)c,b
Per 5-year increase 53 728 (100) 427 (100) 1.09 0.99 1.20 141 (100) 1.15 0.97 1.37 114 (100) 1.20 1.00 1.44
o25c 19 608 (36) 162 (38) 1.0 Reference 53 (38) 1.0 Reference 32 (28) 1.0 Reference
25–29 17 174 (32) 140 (33) 1.08 0.85 1.37 47 (33) 1.06 0.71 1.60 44 (39) 1.67 1.05 2.67
30–34 11 769 (22) 90 (21) 1.17 0.89 1.54 25 (18) 1.00 0.60 1.65 29 (25) 1.85 1.09 3.13
X35 5177 (10) 35 (8) 1.25 0.85 1.85 16 (11) 1.88 1.02 3.48 9 (8) 1.62 0.75 3.51
Paternal age (years)c,d
Per 5-year increase 48 000 (100) 380 (100) 1.10 1.01 1.20 130 (100) 1.16 1.01 1.33 107 (100) 1.13 0.96 1.32
o25 10 112 (19) 73 (19) 1.0 Reference 22 (17) 1.0 Reference 21 (20) 1.0 Reference
25–29 14 698 (27) 124 (33) 1.19 0.88 1.59 45 (35) 1.39 0.83 2.33 33 (31) 1.09 0.63 1.91
30–34 13 287 (25) 109 (29) 1.31 0.96 1.79 36 (28) 1.44 0.83 2.49 34 (32) 1.40 0.80 2.45
X35 9903 (21) 74 (19) 1.36 0.96 1.91 27 (21) 1.68 0.93 3.05 19 (18) 1.20 0.63 2.28
Gestational age (weeks)a,b
o37 4266 (8) 45 (11) 1.27 0.89 1.82 18 (13) 1.87 1.07 3.27 10 (9) 1.35 0.65 2.79
37–42 45 997 (86) 353 (83) 1.0 Reference 115 (82) 1.0 Reference 97 (85) 1.0 Reference
442 3465 (6) 29 (7) 1.05 0.71 1.53 8 (6) 0.93 0.45 1.91 7 (6) 0.93 0.43 2.00
Pluralitya,b
Multiple 1203 (2) 6 (1) 0.55 0.24 1.28 3 (2) 0.89 0.27 2.98 1 (1) 0.43 0.06 3.21
Single 52 525 (98) 421 (99) 1.0 Reference 138 (98) 1.0 Reference 113 (99) 1.0 Reference
Birth weight (g)a,b
Per 500 g 53 728 (100) 427 (100) 0.99 0.90 1.09 141 (100) 1.02 0.87 1.20 114 (100) 1.02 0.85 1.23
o2500 2911 (5) 32 (7) 1.27 0.83 1.95 9 (6) 0.76 0.35 1.65 5 (4) 0.82 0.30 2.26
2500–4000 43 989 (82) 346 (81) 1.0 Reference 123 (87) 1.0 Reference 90 (79) 1.0 Reference
44000 6828 (13) 49 (11) 1.02 0.75 1.38 9 (6) 0.59 0.30 1.17 19 (17) 1.31 0.80 2.17
Birth ordera,b
1 22 008 (41) 177 (41) 1.0 Reference 60 (43) 1.0 Reference 47 (41) 1.0 Reference
2 17 543 (33) 142 (33) 0.98 0.78 1.23 45 (32) 0.89 0.59 1.32 42 (37) 1.01 0.66 1.55
3 8661 (16) 67 (16) 0.91 0.68 1.22 20 (14) 0.78 0.46 1.32 18 (16) 0.85 0.48 1.49
X4 5516 (10) 41 (10) 0.83 0.58 1.20 16 (11) 0.91 0.50 1.67 7 (6) 0.49 0.21 1.12
Abbreviations: CI¼ confidence interval; OR¼ odds ratio. aAdjusted for state (CA, WA, MN, NY, TX), birth year category (1970–85, 1986–89, 1990–93, 1994–2004), maternal
race (white, other), sex (male, female), maternal age as a continuous variable, gestational age (o37, 37–42,442 weeks), plurality (multiple, single), birth weight (o2500, 2500–4000,
44000 g), and birth order (1, 2, 3,X4). b4238 controls and 48 total carcinoma cases (n¼ 18 thyroid carcinoma and 12 malignant melanoma cases) were excluded due to missing data
on one or more covariates. cAdjusted for state (CA, WA, MN, NY, TX), birth year category (1970–85, 1986–89, 1990–93, 1994–2004), maternal race (white, other), sex (male,
female), gestational age (37–42,o37,442 weeks), plurality (multiple, single), birth weight (o2500, 2500–4000,44000g), and birth order (1, 2, 3,X4). d9966 controls and 95 total
carcinoma cases (29 thyroid carcinoma and 19 malignant melanoma cases) were excluded due to missing data on one or more covariates.
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CI 1.07–3.27). Also of note is that the risk for melanoma appeared
to decrease in relation to increasing birth order category, albeit
CIs were wide; for birth orders of four or higher vs first born the
OR was 0.49 (95% CI 0.21–1.12).
We also explored whether associations between parental age and
childhood carcinomas varied by age of diagnosis and sex
(Supplementary Table 1). The risk estimates for the association
between parental age and childhood carcinoma for those
diagnosed p11 years of age vs 411 years of age were generally
similar. However, we note that there was a consistently stronger
parental age association for individuals in the younger vs older age
category. Associations between parental age and carcinomas
between sexes were not statistically significantly different.
DISCUSSION
In addition to the previously documented risk factor for melanoma
of white race, (Schottenfeld and Fraumeni, 2006) we observed a
weak parental age effect for both thyroid carcinomas and
melanomas. For thyroid carcinomas, the data suggest a paternal
age effect, whereas for melanomas the data support a maternal age
effect. We also observed an increased risk of thyroid carcinoma in
association with gestational ageo37 weeks and a decreased risk of
melanoma with increasing birth order.
Older parental age has been associated with a modest risk
increase for several of the more common childhood cancers
including leukaemia, central nervous system tumours, and Wilm’s
tumour in some but not all of the larger studies (Dockerty et al,
2001; Yip et al, 2006; Johnson et al, 2009; Schuz et al, 2011). For
malignant melanoma diagnosed at any age, no increased risk was
found in association with maternal or paternal age in a study of all
Norwegian cases (n¼ 709) born between 1967 and 1986 followed
until 31 December 2003 (Franco-Lie et al, 2008). A significant
positive trend with increasing maternal age at first birth but not
birth of the index child was found in a study of 2 594 783 Danes
that included 1674 incident malignant melanoma cases followed
from 1968 to 2002 who were born between 1950 and 2002 (Olesen
et al, 2009). Although it involved older cases than those in our
study, a Swedish study reported a significant 30% excess risk of
malignant melanoma in the offspring (aged 15–53 years) of
mothers who were 440 years compared with those o20 years at
their time of birth, whereas a 28% decreased risk was reported in
the offspring of fathers who were 440 vs o25 at the time of their
birth. No significant associations were found between maternal or
paternal age and thyroid cancer (Hemminki and Kyyronen, 1999),
while another study also found a protective effect of paternal age
on thyroid carcinoma risk (Galanti et al, 1997). The vast majority
of individuals in these studies were 415 years at the time of their
cancer diagnosis.
Several hypotheses have been proposed to explain the increased
risks of various diseases in offspring in relation to advanced
parental age. The most plausible explanation for a paternal age
effect is the accumulation of de novo mutations that are thought to
occur in aging gametes that divide throughout the male lifetime
(Crow, 2000). It is possible that a paternal age effect for young
onset carcinomas could be mediated by de novo mutations in the
paternal germline in genomic regions that predispose to carcino-
mas. The accumulation of mutations as an underlying explanation
for a maternal age effect is less likely because oocyte cell division is
completed before birth. A maternal age effect is well known for
Down syndrome, which is most commonly caused by three copies
of chromosome 21, with the extra copy usually of maternal origin
(Crow, 2000). However, we are not aware of any evidence
supporting an excess of germline chromosomal abnormalities in
childhood carcinoma cases. Other plausible biological hypotheses
for a maternal age effect on disease risk in the offspring could
involve epigenetic and mitochondrial mechanisms. For example,
differences in gene expression have been noted between young
and old oocytes (Hamatani et al, 2004; Steuerwald et al, 2007;
Pan et al, 2008). The extent to which these differences are
transmitted to offspring and could explain an increased childhood
cancer risk of any subtype including carcinomas has not been
well studied. However, transgenerational inheritance of epimuta-
tions is plausible with the report of a maternally inherited
hypermethylated MLH1 allele in a subject with early-onset
colorectal carcinoma (Hitchins et al, 2007). With regard to
mitochondrial mechanisms, it is plausible that maternally
transmitted mitochondrial DNA mutations that increase with age
could be linked to cancer in the offspring (Eichenlaub-Ritter et al,
2011).
Although based on small numbers, our data suggested
stronger associations between older parental age and childhood
carcinomas in younger individuals which would be consistent with
the hypothesis of an underlying genetic predisposition caused by
an increased frequency of germline mutations in older parents
(Arver et al, 2000). However, it is also possible that advanced
parental age could be a proxy for other non-genetic factors that are
related to childhood cancer risk. Because our data set contained
only a limited number of birth record variables, we could not
assess whether the parental age associations were confounded by
factors plausibly related to older parental age and the carcinomas
under study such as vacation sun exposure for melanoma
(Jen et al, 2009).
We observed a nearly two-fold increased risk of thyroid
carcinoma in individuals born o37 weeks. To our knowledge,
no previous study has examined the association between thyroid
carcinoma and gestational age. Further study is necessary to
determine if this finding could be the related to medical exposures
that occur more frequently in pre-term infants, such as diagnostic
radiation (Pizzo and Poplack, 2006; Lai and Bearer, 2008;
Papadopoulou and Efthimiou, 2009).
The association between birth order and malignant melanoma
has been examined in two studies conducted in Denmark
and Sweden (Hemminki and Mutanen, 2001; Olesen et al, 2009).
InB2.5 million Danes born from 1950 to 2002 that were followed
for incidence cutaneous malignant melanoma diagnoses (n¼ 1674)
at all ages (i.e., children and adults), individuals with birth orders
of five or higher had a significantly reduced risk of melanoma
(IRR¼ 0.24, 95% CI 0.06–1.01); however this result was based on
only two cases in the highest birth order category (Olesen et al,
2009). In Sweden, in 1.38 million individuals o55 years who were
born during 1958–1996 and followed for melanoma diagnoses
(n¼ 1101), a nonsignificant reduction in risk of 5% was observed
per one unit increase in birth order (Hemminki and Mutanen,
2001). Further study is necessary to evaluate the role of birth order
in malignant melanoma.
A strength of our study is that it is large and population based
with birth characteristic data obtained before diagnosis. To
our knowledge, this is the first study to specifically address the
relationship between birth characteristics and paediatric carcino-
mas. Our study also has limitations. Although the accuracy of
some characteristics may not be optimal, the variables that we
used generally have high validity (Northam and Knapp, 2006) and
any misclassification should be non-differential with regard to case
vs control status. Because childhood carcinomas are rare,
our statistical power to detect weak or modest associations was
limited and thus our results should be considered exploratory.
We also did not have follow-up of our control population, which
could have resulted in missed cases. For example, if a control
moved out of state and developed a childhood carcinoma, he/she
would have not been included as a case in our data set. However,
because childhood carcinomas are very rare it is unlikely that
any controls developed this type of cancer; therefore it is also
unlikely that this type of bias affected our results. Missing
data could have biased the results if those with complete data
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were systematically different from those with missing data. The
percentage of cases and controls with missing data on the variables
included in this analysis was similar and generallyo10% (with the
exception of paternal age at 11%) making it seem unlikely that
missing data had a strong influence on our results. Finally, it is
possible that chance variation could be an explanation for our
results.
In summary, we found that our results for childhood carcinomas
reflected the same patterns seen for adults of a positive association
between white race and melanoma. We found no evidence for an
association between most other birth characteristics and childhood
carcinomas with the possible exception of a relationship between
birth order and melanoma, low gestational age and thyroid
carcinoma, and a parental age effect for childhood carcinomas
overall, and melanoma and thyroid carcinoma specifically.
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